CD4 and colorectal cancer: Additionally, it counteracted colorectal cancer in a mouse model, increasing anti-inflammatory cells (CD4+ Tregs and CD4+ IL-10+ cells), and decreased pro-inflammatory cells such as T helper (Th)1 and Th17 cells (342).